Health Research Translation

Evidence-based medicine (EBM) has emphasised that potential advances in healthcare must be tested and proven to do more good than harm before they are incorporated into medical practice. The E of EBM comes from the underpinning published research that is translated from the laboratory bench to the patients’ bedside. Despite this, however, there is little or no training in how to ensure translatability and usefulness of this fundamental ingredient in research for patient benefit. This book fills the gap by focusing on how research translation can be maximised to make EBM truly achievable. Reflecting the author’s considerable experience as both researcher and clinician, the book challenges debate that EBM as currently described is not fit for purpose, provides an analysis of why this is so and offers solutions as to what can be done to change the situation. Key Features:Provides objective analysis of why EBM is failing and what are the remediesDescribes how effective patient-researcher collaboration can be built through efforts and methods to engage citizens in the design, conduct and publication of studies Shows how responsible research publication should seek the input of lay reviewers to make the E of EBM patient-relevantDemonstrates how knowledge transfer can be underpinned by translatable, comprehensive evidence synthesesBy consolidating related themes in the translation journey, starting with citizen involvement in science all the way through to knowledge transfer, this unique book provides invaluable guidance to and will stimulate debate among masters and doctoral students undertaking courses in evidence-based medicine, health research methods, epidemiology and medical statistics and will also be of value to biomedical researchers, medical journal editors and peer reviewers, clinicians including doctors, nurses and allied professionals who recruit patients into health research, patient and public representatives who engage in health research, systematic reviewers, guideline writers, pharmaceutical industry professionals, medical journalists, medical writers, and any individual involved in evidence-based medicine.